US Patent Issued to Memorial Sloan Kettering Cancer Center on Feb. 10 for "Methods for neural conversion of human embryonic stem cells" (New York, California Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,891, issued on Feb. 10, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"Methods for neural conversion of human embryonic stem cells" was invented by Stuart Chambers (San Francisco) and Lorenz Studer (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to the field of cell biology of stem cells, more specifically the directed differentiation of pluripotent or multipotent stem cells, including human embryonic stem cells (hESC), somatic stem cells, and induced human pluripotent stem cells (hiPSC) using novel culture conditions. Specifically, methods are provided for obtaining neural tissue...